Description & Catalogue - aandp.fr · original molecule structure demonstrates a pharmacological effect, which none of its chemical components has. ATP-LONG’s effet is anti-ischemial,

S'il vous plaît connaissez les informations sur le

fabricant ukrainien, le fournisseur de produits

pharmaceutiques: compléments alimentaires /

nutritionnels, désinfectants / CP, substances / extraits

phytochimiques.

A propos de la société: la société pharmaceutique innovante du niveau européen, qui intègre avec succès le potentiel scientifique de haute technologie et la fabrication moderne dans un complexe efficace; elle fabrique des produits selon les normes internationales de qualité

A propos de la production: La société a mis en place un systèmede qualité pharmaceutique intégré (IPQS).Le contrôle de la qualité est exercé à toutes les étapes du cycle de production.

Avantages concurrentiels: Les laboratoires physico-chimiqueset microbiologique fournissent le contrôle de la qualité sw la matière première en entrée, le contrôle des produitsintermédiaires, le contrôle des produits finis et surveillent les conditions sanitaires de production.

Produits pharmaceutiques, médecine

Description & Catalogue

Catalogue de produits

• Activated charcoal• Allochol• Altan• Hematogen• Metoclopramide

Hydrochloride• Normolact• Nystatin• Ondansetron

(intravenous solution)• Ondansetron (tablets)• Vinboron®

A - alimentary tract and metabolism


MEDICINAL PRODUCTS


VINBORON®Active substance:20 or 40 mg of vinboron.VINBORON is a synthetic drug that has local anaesthetic and pronounced antispasmodic effects. It reduces the tone and motility of smooth muscles, relieves or prevents spasms of smooth muscles of internal organs, including the digestive tract. This medicine dilates the coronary and cerebral vessels, thus, improves coronary and cerebral blood flow; in chronic use it produces anti-sclerotic effect. Vinboron has mild thrombolytic effect, and mild broncholytic and immunostimulating effects.

IndicationsVINBORON is used as an antispasmodic agent to treat digestive tract diseases:•disorders of the gall bladder and Oddi's sphincter (hyperkinetic biliary dyskinesia, sphincter of Oddi dysfunction);•irritable bowel syndrome with constipation.The drug is used in combination therapy of cerebral circulation disorders.

Dosage and pharmaceutical form:Film-coated tablets 40 mg, 10 tablets in blister, 4 blisters in package.


ALLOCHOL

Active ingredients:dry or condensed bile - 80 mg, dried garlic - 40 mg, nettle lleaves - 5 mg, activated charcoal - 25 mg.ALLOCHOL improves the secretory function of hepatocytes (primary liver cells); it has a mild choleretic action and stimulates the synthesis of bile acids. It improves secretory and motor functions of the gastrointestinal tract by inhibiting the growth of pathogenic organisms and abnormal fermentation in the intestines.

Indications•chronic cholecystitis;•uncomplicated cholelithiasis (gallstones);•gallbladder dyskinesia;•postcholecystectomy syndrome;•slow transit constipation, and uncomplicated gallbladder cholesterolosis.

Dosage and pharmaceutical form:film-coated tablets, 10 or 50 tablets in blister; 10 tablets in blister, 5 blisters in package; 180 tablets in container and package.


NYSTATIN

Active ingredients:Nystatin 500,000 IU.NYSTATIN selectively inhibits pathogenic flora; it is active against a wide range of yeasts and yeast-like fungi, including Candida and Aspergilla.

Indications• the prevention and treatment of candidal

infections caused by Candida Spp;• (Candida Albicans, etc.) of the oral cavity,

oesophagus skin and gastrointestinal tract.

Dosage and pharmaceutical form:film-coated tablets, 10 tablets in blister, 2 blisters in package; 20 tablets in blister, 1 blister in package.

*Les informations sur d'autres médicaments et la coopération peuventetre demandés par vous rapidement à travers le formulaire sur le site Web, après quoi nous vous contacterons directement avec le fabricant.


• Atrogrel• Feroplect• Ferumbo

B - blood and blood forming organs

FEROPLECT

Active substance:50 mg of ferrous sulphate heptahydrate, 30 mg of ascorbic acid.FEROPLECT is a product for regulating metabolic processes. In particular, this product restores iron deficiency in case of iron deficiency anaemia of various origins, and stimulates erythropoiesis.

Indications• used to treat and prevent iron deficiency anaemia.

Dosage and pharmaceutical form:coated tablets, 50 tablets in blister and envelope; No. 10х3, No. 10х6 in blisters and package.


ATROGREL

Active ingredients:Clopidogrel as clopidogrel bisulphate 75 mg.ATROGREL is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. The active metabolite of clopidogrel selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet P2Y12 receptor, and the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIacomplex, thereby inhibiting platelet aggregation. Platelet aggregation induced by agonists other than ADP is also inhibited by blocking the amplification of platelet activation by released ADP. Inhibition of platelet aggregations is observed within 2 hours after administration of a single dose. Repeated doses of 75 mg per day produced substantial inhibition of ADP-induced platelet aggregation from the first day; this increased progressively and reached steady state between Day 3 and Day 7. At steady state, the average inhibition level observed with a dose of 75 mg per day was between 40% and 60%. Platelet aggregation and bleeding time gradually returned to baseline values, generally within 5 days after treatment was discontinued.

IndicationsATROGREL is indicated in adults for the prevention of atherothromboticevents in:• Patients suffering from myocardial infarction (from a few days until less

than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

• Patients suffering from acute coronary syndrome: - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

Dosage and pharmaceutical form:film-coated tablets 75 mg, 10 tablets in blister, 1 blister in package; 10 tablets in blister, 3 blisters in package.


FERUMBO

Active ingredients:iron as iron III hydroxide polimaltosecomplex 50 mg/5 ml of syrup.FERUMBO is a preparation that combines ferric hydroxide (III) with polymaltose, which compensate for iron deficiency in the body. It stimulates hemo- and erythropoiesis and is very safe.

Indications• the prevention and treatment of iron deficiency and anemia of

various geneses in children. In adults, FERUMBO is indicated in iron deficiency (polymenorrhea, metrorrhagia, childbirth, piles, peptic ulcer, duodenal ulcer, surgery, frequent epistaxis);

• when need in iron is higher during pregnancy and lactation, donorship, burns, hemodialysis; alimentary iron deficiency, malabsorption, chronic diarrhea, regional enteritis, enteritis and malabsorption.

Dosage and pharmaceutical form:syrup 50 mg/5 ml, 50 ml or 100 ml in vial and package with dosage device; 100 ml in bottle and package with dosage device


• Arytmil (tablets, intravenous solution)

• ATP-LONG®• Biprolol• Corvitin®• Cratal• Cratal for children• Digoxin• Epletor• Furosemide• Hydrochlorothiazide• Indopres• Indovenol• Liprazide 10• Liprazide 20• Lipril• Mexarithm• Mononitrosid• Nimodipine• Nitrosorbid• Quercetin• Quertin• Riboxin-BCPP• Venohepanol• Venorutinol• Verapamil Hydrochloride• Veratard 180

C - cardiovascular system


CRATAL

Active ingredients:taurine - 867 mg, thick extract of motherwort (Leonuriae herbaextractum spissum) - 87 mg, thick extract of haws (Сrataegiae fructusextractum spissum) - 43 mg.CRATAL has a mild cardiotonic, antianginal, antioxidant, antiarrhythmic, antihypoxic, and antiaggregant effects. The preparation relieves the symptoms of digitalis intoxication. It increases physical performance and improves mood, and it has a sedative and neuroprotective effect, improving somatonegative disorders, such as irritation and fluctuation of mood.

Indications• used to treat neurocirculatory dystonia;• in combination therapy;• used to treat chronic cardiac ischemia;• post-radiation syndrome.

Dosage and pharmaceutical form:tablets, 10 tablets in blister, 2 blisters in package; 60 tablets in container; 60 tablets in container and package; 90 tablets in container; 90 tablets in container and package; 1000 tablets “in bulk” in polyethylene bags.


ATP-LONG®

Active ingredients:ATP-LONG 10 mg or 20 mg, Adenine Nucleotide 6.3 g/12.6 g.ATP-LONG is a unique new class medicine containing adenosine-5’-triphosphate (ATP), histidine amino acid, magnesium and potassium. Its original molecule structure demonstrates a pharmacological effect, which none of its chemical components has. ATP-LONG’s effect is anti-ischemial, membrane stabilizing and antiarrhythmic. ATP-LONG normalizes metabolism, improves the myocardial anti-oxidation protection system, and reduces accumulation of hydrolysis products in membranes and the peroxidation of phospholipids. ATP-LONG improves central and peripheral hemodynamics and coronary blood circulation, and increases myocardial contractile ability, the function of the left ventricle and cardiac output, resulting in better physical efficiency. ATP-LONG reduces the frequency of stenocardia, normalizes potassium and magnesium tissue concentrations and reduces uric acid concentrations.

Indications• indicated for the treatment of cardiac ischemia, unstable stenocardia;• post-infarction and myocardial cardiosclerosis;• cardiac insufficiency;• tachycardia;• vegetovascular dystonia;• myocardial dystrophy;• infectious allergic myocarditis;• chronic fatigue syndrome.

Dosage and pharmaceutical form:tablets 10 mg or 20 mg, 10 tablets in blister, 4 blisters in package.


CORVITIN®

Active ingredients:quercetin complex with polyvinyl pyrrolidone -0.5 g.CORVITIN is a bioflavonoid, capillary stabilizer and antioxidant agent in metabolic processes.

Indications• used as a cardioprotector in combination therapy of acute coronary

circulation failure and myocardium infarction;• and in the treatment and prevention of reperfusion syndrome in

surgery in patients with obliterating atherosclerosis of the abdominal aorta and peripheral arteries.

Dosage and pharmaceutical form:lyophilizate for injection 0.5 g in vials, 5 vials in cassette, 1 cassette in case.


BIPROLOL

Active ingredients:5 mg or 10 mg Bisoprolol fumarate.BIPROLOL is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilisingactivity. Bisoprolol has a cardioselectivity 1:75. It reduces the heart rate (HR) in both rest and physical exercise conditions, decreasing cardiac output and slightly increasing general peripheral vascular resistance. It slows down atrioventricular conduction and prolongs the AV node refraction time.

Indications• arterial hypertension;• stable chronic angina;• stable chronic heart failure with reduced systolic left ventricular

function in addition to ACE inhibitors, and diuretics, and optionally cardiac glycosides.

Dosage and pharmaceutical form:tablets 5 mg or 10 mg, 10 tablets in blister, 3 blisters in package; 60 tablets in container and package; 90 tablets in container and package.




D - dermatological

• Balsamic Liniment (by Vishnevsky)

• Clotrex• Clotrimazole (ointment,

solution)• Gentasept• Griseofulvin• Laevomecol• Mezoderm• Povidone-Iodine

LAEVOMECOL

Active ingredients:100 g of ointment contains Chloramphenicol (Laevomycetin) - 0.75 g, Methyluracil - 4 g.LAEVOMECOL is a topical combination product that has anti-inflammatory, reparative and anti-microbial action.

Indications• used for the treatment of purulent wounds (combined infection) in

the first phase of wound healing; ulcers, bed sores, infected burns, blotches, carbuncles.

Dosage and pharmaceutical form:ointment 30 g or 40 g in tube, 1 tube in package.


CLOTRIMAZOLE (OINTMENT, SOLUTION)

Active ingredients:1 g ointment contains Clotrimazole - 10 mg;1 ml of solution containing Clotrimazole - 10 mg.CLOTRIMAZOLE is an antimycotic imidazole derivative. Clotrimazole acts against fungi by inhibiting ergosterol synthesis, which leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.

Indications• indicated for the treatment of fungal skin and mucosa infections due to

dermatophytes, yeasts, moulds and other fungi susceptible to Clotrimazole;

• skin infections caused by Malassezia Furfur (pityriasis versicolor) and

Corynebacterium Minutissimum (erythrasma).

Dosage and pharmaceutical form:1 % ointment 25 g in tube and package;1% solution 25 ml in vial, 25 ml in vial and package.


GRISEOFULVIN

Active ingredients:Griseofulvin - 125 mg.GRISEOFULVIN is an antifungal agent that is used to treat fungal infections of the skin and nails. It is produced by culture of some strains of the mold Penicillium Griseofulvum. It is an antimycotic agent active against various dermatomycetes (Trichophyton, Microsporum, Epidermophyton). On entering the systemic circulation, griseofulvin binds to keratin in keratin precursor cells, thereby making them resistant to fungal infections. The medicine only reaches the site of action when hair or skin is replaced by the keratin-griseofulvin complex. Griseofulvin then enters the dermatophyte through energy dependent transport processes and binds to the fungal microtubules, interfering with, and inhibiting mitosis, and the deposition of fungal cell walls.

Indications• used for the treatment of fungal infections of the skin, scalp, hair or

nails (Tinea barbae, Tinea capitis, Tinea corporis, Tinea cruris, Tinea pedis, Tinea unguium) where topical therapy is considered inappropriate, or the infection has proven refractory to topical therapy.

Dosage and pharmaceutical form:tablets 125 mg, 20 tablets in blister, 2 blisters in package.




G - genito urinary system and sex hormones

• Clotrimazole (tablets)• Tamsulid

CLOTRIMAZOLE (TABLETS)

Active ingredients:Clotrimazole - 100 mg.CLOTRIMAZOLE is an antimycotic imidazole derivative. Clotrimazole acts against fungi by inhibiting ergosterol synthesis, which leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazolehas a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.

Indications• indicated for the topical treatment of fungal infections in the genital area

(vaginitis) (usually caused by Candida spp.) and superinfection caused by bacteria susceptible to Clotrimazole.

Dosage and pharmaceutical form:vaginal suppositories 100 mg, 10 tablets in blister, 1 blister in package.


TAMSULID

Active ingredients:Tamsulosin hydrochloride 0.4 mg.TAMSULOSIN is a selective α1 receptor antagonist that binds selectively and competitively to postsynaptic α1A adrenoreceptors in the prostate versus α1B receptors in the blood vessels.

Indications• lower urinary tract symptoms (LUTS) associated with benign

prostatic hyperplasia (BPH). Tamsulosin binds selectively and competitively to postsynaptic α1A adrenoreceptors, which convey smooth muscle contraction, thereby relaxing prostatic and urethral smooth muscle. TAMSULOSIN increases the maximum urinary flow rate by relaxing prostatic and urethral smooth muscle, thus relieving obstruction.

Dosage and pharmaceutical form:capsules with modified release 0.4 mg, 10 capsules in blister, 3 blisters in package.


J - antiinfectives for systemic use

• Altabor• Azithromycin-BCPP• Cebopim• Cefalexin• Cefazolin-BCPP• Cefobocid• Cefopectam• Cefotaxime-BCPP• Ceftractam• Ceftriaxone-BCPP• Cefuroxime-BCPP• Doxycycline• Erythromycin• Ethambutol• Isoniazid• Laevomycetin• Lincomycin Hydrochloride• Nitroxoline• Pyrazinamide• Rifampicin• Tetracycline Hydrochloride• Zacef


AZITHROMYCIN-BCPP

Active ingredients:Azithromycin - 250 mg.AZITHROMYCIN is a macrolide antibiotic with a broad-spectrum antimicrobial action. AZITHROMYCIN inhibits bacterial protein biosynthesis by reversibly binding to the ribosomal 50s sub-unit and inhibiting the translocation of peptides. AZITHROMYCIN is active against gram-positive aerobic bacteria, some of grampositive anaerobic bacteria, and gram-negative aerobic bacteria. AZITHROMYCIN is also active against intracellular and other microorganisms. Erythromycin-resistant microorganisms most probably are resistant to AZITHROMYCIN.

IndicationsAZITHROMYCIN is indicated for the treatment of the following infections if caused by microorganisms susceptible to AZITHROMYCIN:• ear, nose, throuat infections, upper respiratory tract infections

(sinusitis, otitis media, bacterial pharyngitis, tonsillitis);• lower respiratory tract infections (bacterial bronchitis, pneumonia);• skin and soft tissue infections (erysipelas, impetigo, secondary

pyodermatoses);• erythema migrans (early Lyme desease);• urogenital infections (uncomplicated Chlamydia trachomatis urethritis

and cervicitis).

Dosage and pharmaceutical form:capsules 250 mg, 6 capsules in blister, 1 blister in package.


CEFOTAXIME-BCPP

Active ingredients:Cefotaxime as sterile cefotaxime sodium - 500 mg or 1000 mg.CEFOTAXIME-BCPP is a beta-lactam antibiotic in the third-generation class of cephalosporins for intramuscular or intravenous administration. This broad-spectrum antibiotic is active against numerous gram-positive and gram-negative bacteria. It is effective against strains resistant to penicillin, streptomycin and sulfanilamides.

IndicationsCEFOTAXIME-BCPP is indicated for the treatment of infections caused by susceptible microorganisms:• infections of the ear, nose, throat (tonsillitis, otitis);• respiratory tract infections (bronchitis, pneumonia, pleuritis,

abscesses);• urogenital tract infections;• septicemia, bacteremia;• intra-abdominal infections (including peritonitis);• skin and soft tissue infections;• bone and joint infections;• meningitis (excluding those caused by Listeria spp.) and other CNS

infections;• also used for the prevention of postoperative infection

(gastrointestinal tract, urological and obstetrical surgery).

Dosage and pharmaceutical form:powder for solutions for injection 500 mg or 1000 mg in vials, 5 vials in cassette, 1 cassette in case; 1 vial without the package, 55 vials in the box; 1 vial together with solvent (water for injection) 5 ml in ampoule per cassette, 1 cassette in case, № 1 vial with powder.


ETHAMBUTOL

Active ingredients:Ethambutol Hydrochloride - 400 mg.ETHAMBUTOL is bacteriostatic. It is effective against Mycobacterіum tuberculosіs, and some atypical mycobacteria (M.avium, M.kansasii, M.xenopi). Ethambutol inhibits growth of mycobacteria resistant to streptomycin, isoniazid, paraaminosalicylic acid, ethionamide, kanamycin and tuberculostatics.

Indications• indicated for the treatment of all forms of pulmonary and

extrapulmonary tuberculosis (in combination with other anti-TB medicines).

Dosage and pharmaceutical form:tablets 400 mg, 10 tablets in blister, 5 blisters in package; 120 tablets in container and package; 1000 tablets in plastic container.


ISONIAZID

Active ingredients:Isoniazid - 100 mg or 200 mg.ISONIAZID is a synthetic bactericidal anti-tubercular agent that is highly active against mycobacterium tuberculosis.

Indications• indicated for the treatment of any form of tuberculosis in combination

with other antitubercular agents.

Dosage and pharmaceutical form:tablets 100 mg, 1000 tablets in container.tablets 200 mg, 10 tablets in blister, 5 blisters in package; 1000 tablets in container.




M - musculo-sceletal system

• Allopurinol• Bofen• Diclofen-gel• Ibuprofen• Ibutard 300

BOFEN

Active ingredients:1 ml suspension contains Ibuprophen 20 mg (100 mg/5 ml).BOFEN is a propionic acid derivative NSAID that inhibits prostaglandin synthesis. BOFEN has antipyretic, anti-inflammatory and analgesic action. BOFEN reduces inflammatory pain, swelling and fever. Furthermore, BOFEN reversibly inhibits platelet aggregation.

IndicationsBOFEN is used to treat:• fever of various origins (including post-vaccination fever);• mild or moderate pain (including headache, toothache, ear and throat

pain, teething pain, pain after the extraction of tooth, sprains, neuralgia, and inflammatory pain).

Dosage and pharmaceutical form:100 mg/5 ml suspension, in 100 ml plastic bottle, 1 bottle in package with measuring spoon; 100 ml in glass or plastic vial, 1 vial in package with measuring spoon.


ALLOPURINOL

Active ingredients:Allopurinol - 100 mg.ALLOPURINOL is is a xanthine-oxidase inhibitor and is used for the treatment of gout. ALLOPURINOL and its main metabolite oxipurinol lower the level of uric acid in plasma and urine by inhibition of xanthine oxidase, the enzyme catalyzing the oxidation of hypoxanthine to xanthine and xanthine to uric acid. This reduces serum urates and prevents their accumulation in the tissues and kidneys.

IndicationsADULTS:ALLOPURINOL is indicated tor the treatment of:• hyperuricemy (the serum level of uric acid is 500 mkmol (8.5 mg/100

ml) or higher and non-diet controlled);• diseases caused by increased serum uric acid levels, especially in

patients with gout, urate nephropathy and urate urolithiasis;• secondary hyperuricemy;• primary and secondary hyperuricemy, accompanied by various

hemoblastoses (acute leucosis, chronic myeloleukemia, lymphosarcoma);

• cytostatic therapy of tumors; myeloproliferative disorders.CHILDREN:• urate nephropathy due to the treatment of leukemia;• secondary hyperuricemy;• congenital deficiencies such as Lesch-Nyhan syndrome (partial or

complete deficiency of hypoxanthine-guanine phosphoribosyltransferase) and congenital deficiency of adenine-phosphoribosyltransferase..

Dosage and pharmaceutical form:tablets 100 mg, 10 tablets in blister, 5 blisters in package.


IBUTARD 300

Active ingredients:Ibuprofen prolonged-release capsules - 300 mg.The active ingredient of IBUTARD 300 ibuprofen reduces inflammation and related pain, and lowers body temperature. The mechanism of action is the inhibition of synthesis of prostaglandins which are mediators of pain, inflammation and fever. IBUTARD 300 prolonged (extended)-release capsules provide 12-hour action, releasing ibuprofen gradually in order to maintain the stable plasma concentrations.tion.

IndicationsBOFEN is used to treat:• indicated for the symptomatic treatment of mild and moderate pains

(headaches, toothache, menstrual pain, muscle pain, rheumatic pain in bones and joints, post-traumatic pain);

• fever.

Dosage and pharmaceutical form:prolong-release capsules 300 mg, 10 capsules in blister, 1 blister in package; 10 capsules in blister, 2 blisters in package.


IBUPROFEN

Active ingredients:Ibuprofen - 200 mg.IBUPROFEN is a propionic acid derivative non-steroidal anti-inflammatory agent that inhibits prostaglandin synthesis. It has anti-inflammatory, analgesic and moderate antipyretic action. The mechanism of action of IBUPROFEN is non-selective inhibition of two isoforms of cyclooxygenase, “COX-1” and “COX-2”. Cyclooxygenase is an enzyme that converts arachidonic acid to prostaglandin H2. Prostaglandin H2 in turn, is converted by other enzymes to several other prostaglandins, which are mediators of pain, inflammation, and fever. The analgesic action of IBUPROFEN is due to both the peripheral mechanism (indirect, through the inhibition of prostaglandin synthesis) and the central mechanism (inhibition of the prostaglandin synthesis in central nervous system). Ibuprofen reversibly inhibits platelet aggregation.

Indications• indicated for the symptomatic treatment of headache,

toothache, migraine, dysmenorrhoea, neuralgia, backache, pain in joints and muscles, rheumatic pains, and febrile state, and signs of cold and flu.

Dosage and pharmaceutical form:film-coated tablets 200 mg, 50 tablets in blister; 10 tablets in blister, 5 blisters in package.


DICLOFEN-GEL

Active ingredients:1 g of gel contains Diclofenac Sodium - 30 mg, Laevomenthol - 5 mg.When applied topically, DICLOFEN-GEL demonstrates pronounced anti-inflammatory, analgesic, anti-edematous and antiaggregant action, associated with the inhibition of the biosynthesis of prostaglandins, kininsand other inflammation mediators. DICLOFEN-GEL reduces capillary wall permeability, stabilizes lysosomal membranes, and lowers the fever at the inflammation site. Menthol, which is a part of the composition, shows immediate analgesic action due to its cooling effect and potentiates the effect of diclofenac. DICLOFEN-GEL helps reduce swelling of the joints and periarticular tissues, relieves pain at rest and in motion, reduces morning stiffness, and increases the joint range of motion, and joint functionality and motor ability. By reducing platelet aggregation, DICLOFEN-GEL improves local microcirculation.

IndicationsDICLOFEN-GEL is applied topically in combination therapy for treatment of inflammations and pain as follows:• localized inflammatory and degenerative diseases of joints and spine,

including osteoarthritis, osteoarthritis of the peripheral joints and spine;

• soft-tissue rheumatic conditions, including tenosynovitis, ‘shoulder-hand’ syndrome, bursitis;

• post-traumatic inflammation of soft tissue, tendons, ligaments, muscles, and joints (sprains, dislocations, overexertion, bruises, swelling).

Dosage and pharmaceutical form:gel, 25 g in tube and package.


N - nervous system

• Borizol• Bupinecaine• Bupinecaine-isobar• Caffeine-Sodium Benzoate• Centrolin• Cofalgin• Cyklodol• Glutalit• Menovalen• Miraxol• Paracetamol for children• Piracetam• Teturam• Trivalumen• Valerica• Valevigran• Vinpocetine


CENTROLIN

Active ingredients:4 ml of the solution (one ampoule) contains choline alfoscerate - 1000 mg.

IndicationsAcute periods of severe craniocerebral injury with symptoms of lesions of the brain stem (impairment of consciousness, comatose condition, focal hemispheric symptoms, and symptoms of lesions of the brain stem).Psycho-organic syndrome associated with degenerative and involuntary changes in the brain or secondary effects of cerebrovascular insufficiency, i.e. primary or secondary disorders of mental performance in elderly people, which are characterized by memory impairment, confused consciousness, disorientation, decreased motivation and initiative, reduced ability to concentrate; emotional and behavioural changes: emotional lability, increased irritability, decreased interest to the environment; age-related pseudo-melancholy.

Dosage and pharmaceutical form:solution for injection, 4 ml per ampoule, 5 ampoules in cassette, 1 or 2 cassettes in package.


BORIZOL

Active ingredients:Riluzole - 50 mg.RILUZOLE is a benzothiazole derivative that inhibits the release of glutamate (the primary excitatory neurotransmitter in the CNS) at the presynaptic nerve endings. RILUZOLE interferes with the neural transmission processes in the brain, which control the motor and sensory functions. BORIZOL promotes independent movement, stimulates motor functions, and temporarily delays the need for tracheotomy and mechanical ventilation in patients with amyotrophic lateral sclerosis.

Indications• used to treat amyotrophic lateral sclerosis.

Dosage and pharmaceutical form:film-coated tablets 50 mg, 10 tablets in blister, 6 blisters in package.


TETURAM

Active ingredients:disulfiram - 150 mg.TETURAM is specific agent for treatment of alcohol addiction. Disulfiram action is associated with the ability to destruct alcohol metabolism. During the administration of Teturam alcohol intake causes the specific poisonous effects (nausea, vomiting, dermahemia, fever sensation, dizziness, etc.) and it results in negative conditioned reflex on organoleptic properties of alcoholic beverages.

Indications• alcohol addiction (secondary prophylaxis in the course of treatment).

Dosage and pharmaceutical form:tablets 150 mg, 10 tablets in blister, 1 or 5 blisters in package.




R - respiratory system

• Ambrotard 75• Ambroxol 15• Ambroxol 30• Ambroxol Hydrochloride• Ketotifen• Licorice root• Montel• Salbroxol• Septefril• Theopec


KETOTIFEN

Active ingredients:5 ml of syrup contains Ketotifen Hydrofumarate - 1mg.KETOTIFEN blocks the release of histamine. As an anti-asthmatic agent, this syrup effectively prevents bronchial spasms while showing no bronchodilatory action. KETOTIFEN is effective for prevention of bronchial asthma, reduces the frequency of the use of corticosteroids, bronchodilators and other medications.

Indications• indicated for long-lasting prevention of bronchial asthma attacks,

allergic bronchitis, asthmatic complications such as hay fever and allergic dermatosis, allergic rhinitis and conjunctivitis, urticaria.

Dosage and pharmaceutical form:syrup 1 mg/5 ml, 50 ml in vials; 100 ml in vials or bottles in package with measuring spoon.


AMBROXOL 30

Active ingredients:5 ml of syrup contains Ambroxol Hydrochloride - 30 mg.AMBROXOL is an effective secretolytic and secretomotorbenzylamine agent. It normalizes impaired bronchial secretions by stimulation of serous cells in the bronchial glands, increases mucous secretion and corrects the balance between the serous and mucous components of expectoration. AMBROXOL increases the amount of surfactant in the lungs and prevents damage of the cells of the lungs by improving clearance of the lungs. It normalizes the rheological indices of sputum and reduces its viscosity and adhesive properties. The preparation stimulates motility of the bronchial ciliary epithelium, preventing its adhesion and promoting mucociliary clearance.

Indications• indicated for the treatment of respiratory disorders accompanied by

difficulties of sputum secretion and of acute chronic obstructive bronchitis, bronchial asthma, bronchiectasis, pneumonia, inflammation of the upper respiratory tract (laryngitis, pharyngitis, sinusitis, rhinitis) and mucoviscidosis.

This product can be used to prevent and treat pulmonary postoperative complications and for the treatment of tracheostoma, before and after bronchoscopy.

Dosage and pharmaceutical form:syrup, 30 mg/5 ml, 100 ml in vials or bottles, 1 vial or bottle in package with measuring spoon.

SALBROXOL

Active ingredients:Ambroxol Hydrochloride - 15 mg, Salbutamol Sulphate - 4 mg.SALBROXOL is a combination medication that improves impaired bronchial secretion. It acts as a secretomotor and broncholytic, and prevents or relieves bronchiospasms.

IndicationsSALBROXOL is used for the treatment of:• bronchial asthma;• chronic obstructive bronchitis;• pulmonary emphysema.

Dosage and pharmaceutical form:tablets, 10 tablets in blister, 2 or 4 blisters in package.





V - different means

PANTHEVENOL

Active ingredients:1 g of gel contains: Venorutinol (Troxerutin) - 20 mg, Dexpanthenol - 30 mg.PANTHEVENOL is a topical anti-inflammatory and antimicrobial medicinal agent.

Indications• combination therapy of pain and swelling of legs in venous

insufficiency;• post-thrombotic syndrome and post-surgical treatment of varicose

veins;• the prophylaxis and treatment of varicose veins, thrombosis, leg ulcer in

local circulation failure;• closed injuries (including sports injuries) including haemorrhages,

haematomas, bruises, sprains;• skin injuries such as scratches, cracks, burns, aseptic surgical wounds,

surgical scars, scar indurations, trophic ulcer, bedsores, cracked nipples, irritation in skin folds.

Dosage and pharmaceutical form:gel 40 g in tube and package.


DIETARY/FOOD SUPPLEMENT

ALCYNARA

Active ingredient:garlic powder – 0.128 g, artichoke extract – 0.100 g.Alcynara is recommended for normalization of metabolism and reduction of blood cholesterol.It has hepatoprotective and mild cholereticproperties.

Dosage and pharmaceutical form:60 tablets per container, 1 container in package.

GLUCOSAMINE C-BCPP

Active ingredients:Glucosamine Hydrochloride – 0.3 g, Ascorbic Acid – 0.025 g.Glucosamine C–BCPP is a dietary supplement, a source of glucosamine, a substrate for building up articular cartilages. If used regularly, glucosamine prevents progressive degeneration of joints and spine. Glucosamine also prevents metabolic changes in cartilages.

Indications• it is used for the treatment of joint pain and

normalising and restoring joint functions.

Dosage and pharmaceutical form:60 capsules in a plastic bottle, 1 bottle in package.


GLUQUAMINE

Active ingredient:D-glucosamine hydrochloride – 0.125 g, N-acetyl-D-glucosamine - 0.125 g, quercetin - 0.08 g.Gluquamine could be added to food intake as additional source of glucosamine and quercetin. It promotes the optimized nutritional conditions for healthy state of locomotor system.

Dosage and pharmaceutical form:60 capsules per container, 1 container in package.

YOHIMBEX & HARMONIA

Active ingredients:Ginseng Root– 0,0999 g. Ascorbic Acid – 0,05 g, Zinc Oxide – 0,02 g, Yohimbine Hydrochloride – 0,005 g, Sodium Selenite - 0.001 g.Indications It is recommended for men for enhancing physical endurance and sexual drive.

Indications• has generally positive effects on men’s sexual

function;• stimulates erection and enhances sexual drive;• has stimulating, tonic, immunomodulatory and

psychostimulant action.

Dosage and pharmaceutical form:10 capsules packed in blister, 2 blisters in a carton, 60 capsules per container, one container in package.


API/ EXTRACTSBELLADONNA SOFT EXTRACTOrigin:Atropa belladonna L. DER: 4,8-5,2:1

Characteristics:Not less than 1,3% of total alkaloids expressed as hyoscyamine (dry extract)

Method of assay:HPLC

MOTHERWORT SOFT EXTRACTOrigin:Leonurus cardiaca L. Leonurus quinquelobatus Gilib. DER: 4,5-5,6:1

Characteristics:Not less than 1,0% of total flavonoids expressed as rutin (dry extract)

Method of assay:Spectrophotometry

CALENDULA SOFT EXTRACTOrigin:Calendula officinalis L. DER: 2,0-3,0:1




HAWTHORN BERRIES SOFT EXTRACTOrigin:Crataegus species DER: 3,0-3,3:1



LIQUORICE DRY EXTRACTOrigin:Glycyrrhiza glabra L. Glycyrrhiza inflata Bat. Glycyrrhiza uralensis Fisch. DER: 4,0-5,0:1

Characteristics:Not less than 8,0% of 18β-glycyrrhizic (dry extract)

Method of assay:HPLC



DISINFECTANTS / MEDICAL DEVICES

STOPINFEKTSIA-100

Active ingredients:ethanol - 66%, 2-amino-2-methyl-1-propanol - 0.16%.STOPinfektsia is a product for disinfection. It is manufactured as antiseptic hand gel. For the ready-to-use gel, no dilution is required, and you don’t have to rinse your hands after application of the gel.

Indications• STOPinfektsia is used for disinfection of hands in many situations:• medical practitioners may use it to sanitise their hands before and

after various manipulations;• it is a useful product for hygienic disinfection of hands of those who

provide personal services, e.g., such professionals as hairdressers, cosmetologists, solarium staff, bath-house staff, etc;

• personnel of food-processing plants may find this hygienic disinfectant for hands useful too;

• a hygienic disinfectant for hands of child minders, and teachers;• a hygienic disinfectant for people working in various public places,

such as public transportation: ambulances, railway transport, ships, automobile and air transport, railroad stations and airports, shops and libraries, etc;

• it may be used at home.

Dosage and pharmaceutical form:gel 50 ml, 250 ml, or 1000 ml in plastic bottles with dispensers.

Pour le contacter vite, veuillez remplir le

formulaire sur le site.

Vous pouvez également obtenir un

catalogue étendu de produits, que nous

vous enverrons avec plaisir.


Documents

Description & Catalogue - aandp.fr · original molecule structure demonstrates a pharmacological effect, which none of its chemical components has. ATP-LONG’s effet is anti-ischemial,